Mar. 2, 2026
Xometry Director Buys $50K in Company Stock
Katharine Weymouth increases her stake in the manufacturing technology firm by over 50%
Mar. 2, 2026
Wall Street Zen Upgrades Supernus Pharmaceuticals to 'Strong-Buy'
Analysts cite positive outlook for the specialty pharmaceutical company's CNS therapies.
Feb. 28, 2026
Xometry CEO Sells Over $1.3 Million in Stock
Randolph Altschuler offloads nearly 32,000 shares as company's stock price declines
Feb. 28, 2026
Wedbush Cuts Xometry Price Target to $60
Analysts lower price target for on-demand manufacturing platform
Feb. 28, 2026
Wall Street Zen Upgrades Supernus Pharmaceuticals to Strong Buy
Analysts cite potential for the company's CNS therapies as key driver for upgrade.
Feb. 11, 2026
Head to Head: Janus International Group vs. Argan Construction Firms
Comparing the two construction companies to determine the superior investment
Feb. 11, 2026
Option Care Health Outperforms Bioqual in Medical Services Comparison
Analysis shows Option Care Health has stronger financials, consensus rating, and growth potential than competitor Bioqual
